Mason Street Advisors’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2015
Q1 | – | Sell |
-58,620
| Closed | -$5.69M | – | 1521 |
|
2014
Q4 | $5.69M | Sell |
58,620
-300
| -0.5% | -$29.1K | 0.04% | 503 |
|
2014
Q3 | $4.6M | Sell |
58,920
-6,610
| -10% | -$516K | 0.04% | 543 |
|
2014
Q2 | $4.14M | Buy |
65,530
+6,380
| +11% | +$403K | 0.03% | 623 |
|
2014
Q1 | $3.97M | Sell |
59,150
-4,930
| -8% | -$331K | 0.03% | 611 |
|
2013
Q4 | $4.12M | Buy |
64,080
+4,780
| +8% | +$307K | 0.03% | 591 |
|
2013
Q3 | $3.8M | Buy |
+59,300
| New | +$3.8M | 0.04% | 445 |
|